Kasper van der Born

1.0k total citations
15 papers, 859 citations indexed

About

Kasper van der Born is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Kasper van der Born has authored 15 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Kasper van der Born's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Kasper van der Born is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Kasper van der Born collaborates with scholars based in Netherlands, United States and Japan. Kasper van der Born's co-authors include Godefridus J. Peters, Patrick Schöffski, G. Greim, J. Wanders, Aarón Sulkes, Ronald de Wit, P. Fumoleau, Francesco Caponigro, G. Comella and Christophe Martin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Kasper van der Born

14 papers receiving 830 citations

Peers

Countries citing papers authored by Kasper van der Born

Since Specialization

Citations

This map shows the geographic impact of Kasper van der Born's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kasper van der Born with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kasper van der Born more than expected).

Fields of papers citing papers by Kasper van der Born

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kasper van der Born. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kasper van der Born. The network helps show where Kasper van der Born may publish in the future.

Co-authorship network of co-authors of Kasper van der Born

This figure shows the co-authorship network connecting the top 25 collaborators of Kasper van der Born. A scholar is included among the top collaborators of Kasper van der Born based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kasper van der Born. Kasper van der Born is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Cell Cycle Effects and Increased Adduct Formation by Temozolomide Enhance the Effect of Cytotoxic and Targeted Agents in Lung Cancer Cell Lines 2009 ·Journal of Chemotherapy ·(unknown), Kasper van der Born, Richard J. Honeywell, Godefridus J. Peters	9
2	Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer 2008 ·Annals of Oncology ·J. Sigmond, Richard J. Honeywell, Tjeerd J. Postma, Clemens M.F. Dirven, Sebastian Lange, Kasper van der Born, Adrianus C. Laan, Johannes C. Baayen, C.J. van Groeningen, Andries M. Bergman, Giuseppe Giaccone, Godefridus J. Peters	74
3	Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts 2008 ·Anti-Cancer Drugs ·Rutger W.H.M. Staffhorst, Kasper van der Born, (unknown), Irene H.L. Hamelers, Godefridus J. Peters, Epie Boven, Anton I.P.M. de Kroon	27
4	Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells 2007 ·British Journal of Cancer ·Olaf H. Temmink, (unknown), Kasper van der Born, Stephen P. Ackland, Masakazu Fukushima, Godefridus J. Peters	44
5	Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung 2007 ·Clinical Cancer Research ·(unknown), Peter W.A. Kunst, Kasper van der Born, (unknown), Walter R. Perkins, Frank G. Pilkiewicz, Román Pérez-Soler, Susan Nicholson, Godefridus J. Peters, Pieter E. Postmus	134
6	Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer 2006 ·Cancer Chemotherapy and Pharmacology ·Judith R. Kroep, Egbert F. Smit, Giuseppe Giaccone, Kasper van der Born, Jos H. Beijnen, C.J. van Groeningen, W. J. F. van der Vijgh, Pieter E. Postmus, Herbert M. Pinedo, Godefridus J. Peters	13
7	Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung 2006 ·Journal of Clinical Oncology ·(unknown), Peter W.A. Kunst, Kasper van der Born, Godefridus J. Peters, Román Pérez-Soler, (unknown), (unknown), Walter R. Perkins, Frank G. Pilkiewicz, Pieter E. Postmus	6
8	The Human Multidrug Resistance Protein MRP5 Transports Folates and Can Mediate Cellular Resistance against Antifolates 2005 ·Cancer Research ·Peter R. Wielinga, Jan Hendrik Hooijberg, (unknown), Ietje Kathmann, Glen Reid, Noam Zelcer, Kasper van der Born, Marcel de Haas, Ingrid van der Heijden, Gertjan J.L. Kaspers, Jan Wijnholds, Gerrit Jansen, Godefridus J. Peters, Piet Borst	107
9	No evidence of gemcitabine accumulation during weekly administration 2005 ·European Journal of Clinical Pharmacology ·Sebastian Lange, Kasper van der Born, Judith R. Kroep, Hanna Jensen, Per Pfeiffer, Ann Cleverly, C.J. van Groeningen, Godefridus J. Peters	14
10	Role of Platelet Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Fluoropyrimidine Sensitivity and Potential Role of Deoxyribose‐1‐phosphate 2005 ·ChemInform ·Michiel de Bruin, (unknown), Kees Smid, Kasper van der Born, Masakazu Fukushima, Klaas Hoekman, Herbert M. Pinedo, Godefridus J. Peters	0
11	Role of Platelet Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Fluoropyrimidine Sensitivity and Potential Role of Deoxyribose‐1‐Phosphate 2004 ·Nucleosides Nucleotides & Nucleic Acids ·Michiel de Bruin, (unknown), Kees Smid, Kasper van der Born, Masakazu Fukushima, Klaas Hoekman, Herbert M. Pinedo, Godefridus J. Peters	12
12	Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation 2004 ·British Journal of Urology ·Ettore De Berardinis, Gabriele Antonini, Godefridus J. Peters, Willem J.P Loves, Kasper van der Born, Giovanni Codacci-Pisanelli, F. Di Silverio	28
13	Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity 2003 ·British Journal of Cancer ·Michiel de Bruin, (unknown), Kasper van der Born, Frank A.E. Kruyt, Masakazu Fukushima, Klaas Hoekman, Herbert M. Pinedo, Godefridus J. Peters	62
14	Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin 2002 ·European Journal of Cancer ·M. Borner, Patrick Schöffski, Ronald de Wit, Francesco Caponigro, G. Comella, Aarón Sulkes, G. Greim, Godefridus J. Peters, Kasper van der Born, J. Wanders, (unknown), Christophe Martin, P. Fumoleau	274
15	Simultaneous determination of intact cisplatin and its metabolite monohydrated cisplatin in human plasma 2002 ·Journal of Chromatography B ·Miranda Verschraagen, Kasper van der Born, (unknown), W. J. F. van der Vijgh	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact